Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

You May Not Have Seen 'It', But 'It' Has Seen You: Commonly Missed Diagnoses in Onco-Dermatology

Description

The presentation discusses the challenges of diagnosing cutaneous T-cell lymphoma (CTCL) in patients with skin conditions, particularly within the context of onco-dermatology. By presenting a series of 19 clinical cases, the speaker emphasizes diagnostic pitfalls and the overlap between dermatological symptoms and cancer treatment effects. Key points include the difficulty of recognizing erythroderma, especially in patients with skin of color, and the misleading nature of biopsy results that might reflect non-specific dermatitis. The discussion highlights the need for thorough evaluations, considering both clinical history and advanced diagnostic tests like flow cytometry and T-cell receptor sequencing. Several patients with persistently itchy skin and flaring conditions were ultimately diagnosed with CTCL or Cesare syndrome after extensive roundabouts in treatment and misdiagnoses. The importance of reevaluating clinical suspicions over time and the risks associated with treatments such as dupilumab in undiagnosed CTCL patients are also noted. Overall, the cases illustrate the need for careful scrutiny in dermatology, particularly regarding potential underlying malignancies that can be easily overlooked.

View more

Conclusions

  • Erythroderma can be difficult to diagnose, especially in patients with skin of color.
  • Spongiosis is a common pathology observed in patients diagnosed with Sézary syndrome.
  • Regular follow-ups and repeat testing are crucial for diagnosing conditions like CTCL.
  • Clinical context and thorough examinations are essential to prevent misdiagnosis in onco-dermatology.
  • Rashes can mimic multiple conditions, complicating the diagnostic process, therefore careful evaluation is mandatory.
  • Dupilumab may exacerbate CTCL symptoms and should only be used when CTCL has been ruled out.
  • There have been numerous cases of CTCL linked to prior dupilumab treatment without proper diagnostic evaluation.
  • Mycosis fungoides (MF) can imitate various skin conditions; thus, biopsies should be repeated if lesions do not respond as expected to treatments.
  • Espinosa et al. J Am Acad Dermatol. 2020 Jul; 83(1): 197-199.